Alec Machiels, Director at Apellis Pharmaceuticals, Inc. (APLS), sold 2,500 shares at $64.03 ($160K) on 2023-03-17, disclosed to the SEC on 2023-03-21.
Seasonal sale ($160k) by Director — this insider has traded APLS in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.03 | 1,250 | $80K | 50.0% |
| 2 | $64.03 | 1,250 | $80K | 50.0% |
| Total | $64.03 avg | 2,500 | $160K | 100% |
| Filing → |
| APLS | SELL | 2023-09-19 | $56K | — | Filing → |
| APLS | SELL | 2023-09-18 | $113K | — | Filing → |
| APLS | SELL | 2023-07-18 | $162K | — | Filing → |